Albuminuria-lowering effect of sodium-glucose cotransporter 2 inhibitors could be partly attributable to the attenuation of tubular damage in type 2 diabetic patients.

Yanagisawa, Katsuyuki; Sotokawauchi, Ami; Nishino, Yuri; Matsui, Takanori; Tahara, Nobuhiro; Yamagishi, Sho-Ichi

Yanagisawa, Katsuyuki; Sotokawauchi, Ami; Nishino, Yuri; Matsui, Takanori; Tahara, Nobuhiro; Yamagishi, Sho-Ichi.

Afiliação

Yanagisawa K; Souen Diabetes Clinic, Sapporo, Japan.
Sotokawauchi A; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Nishino Y; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Matsui T; Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, Japan.
Tahara N; Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Yamagishi SI; Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Diabetes Metab Res Rev ; 36(7): e3327, 2020 Oct.

Article em En | MEDLINE | ID: mdl-32319149

Palavras-chave

SGLT2; advanced glycation end products; albuminuria; diabetic nephropathy; tubular damage

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diabetes Metab Res Rev Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google